KLF5 controls subtype-independent highly interactive enhancers in pancreatic cancer to regulate cell survival

Thomas L. Ekstrom(Mayo Clinic), Steven A. Johnsen(University of Göttingen)
Science Advances
March 18, 2026
Cited by 0


Related Papers